Our team can help you strategize the timing of your transition to align with your lifestyle and health goals, ensuring that the new regimen supports both your diabetes management and overall wellness
One of the main side effects of the medication is nausea, which can significantly interrupt your daily routine
Efficacy, side effects, dosing schedule, and FDA indications are identical
A more mindful, wellness-forward approach to GLP-1 use
13.7% (December 4, 2024) Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity (July 8, 2024) Metformin: Therapeutic profile in the treatment of type 2 diabetes (May 24, 2024) Effects Of Alpha-Glucosidase-Inhibiting Drugs On Acute Postprandial Glucose And Insulin Responses: A Systematic Review And Meta-Analysis (March 03, 2021) Clinical Use of DPP-4 Inhibitors (June 19, 2019) Meglitinide Analogues For Type 2 Diabetes Mellitus (April 18, 2007) The Current Role Of Sodium-Glucose Cotransporter 2 Inhibitors In Type 2 Diabetes Mellitus Management (May 25, 2022)